Clinical Trial

A Study of XS-04 in Patients with Relapsed or Refractory Hematologic Malignancies

Name: A Study of XS-04 in Patients with Relapsed or Refractory Hematologic Malignancies — clinical trial record (NCT06820268)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

Evaluation of the safety, tolerability, pharmacokinetics, and preliminary efficacy of XS-04 in patients with relapsed or refractory hematologic malignancies

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-02-05.

Status change: Enrolling by Invitation → Recruiting 2025-02-27

Trial Details

NCT Number	NCT06820268
Lead Sponsor	NovaOnco Therapeutics Co., Ltd.
Conditions	B-cell Lymphoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome
Enrollment	168 participants
Start Date	2025-01-14
Primary Completion	2027-11-01 (estimated)
Study Completion	2028-03-15 (estimated)
Updated on ClinicalTrials.gov	2025-03-04